Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system

David Voehringer, Tiffany A. Reese, Xiaozhu Huang, Kanade Shinkai, Richard M. Locksley

Research output: Contribution to journalArticle

230 Citations (Scopus)

Abstract

Nippostrongylus brasiliensis infection and ovalbumin-induced allergic lung pathology are highly interleukin (IL)-4/IL-13 dependent, but the contributions of IL-4/IL-13 from adaptive (T helper [Th]2 cells) and innate (eosinophil, basophils, and mast cells) immune cells remain unknown. Although required for immunoglobulin (Ig)E induction, IL-4/IL-13 from Th2 cells was not required for worm expulsion, tissue inflammation, or airway hyperreactivity. In contrast, innate hematopoietic cell-derived IL-4/IL-13 was dispensable for Th2 cell differentiation in lymph nodes but required for effector cell recruitment and tissue responses. Eosinophils were not required for primary immune responses. Thus, components of type 2 immunity mediated by IL-4/IL-13 are partitioned between T cell-dependent IgE and an innate non-eosinophil tissue component, suggesting new strategies for interventions in allergic immunity. JEM

Original languageEnglish (US)
Pages (from-to)1435-1446
Number of pages12
JournalJournal of Experimental Medicine
Volume203
Issue number6
DOIs
StatePublished - Jun 12 2006

Fingerprint

Interleukin-13
Interleukin-4
Immune System
Immunity
Th2 Cells
Eosinophils
Immunoglobulin E
Nippostrongylus
Basophils
Ovalbumin
Mast Cells
Cell Differentiation
Lymph Nodes
Pathology
Inflammation
T-Lymphocytes
Lung
Infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. / Voehringer, David; Reese, Tiffany A.; Huang, Xiaozhu; Shinkai, Kanade; Locksley, Richard M.

In: Journal of Experimental Medicine, Vol. 203, No. 6, 12.06.2006, p. 1435-1446.

Research output: Contribution to journalArticle

Voehringer, David ; Reese, Tiffany A. ; Huang, Xiaozhu ; Shinkai, Kanade ; Locksley, Richard M. / Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. In: Journal of Experimental Medicine. 2006 ; Vol. 203, No. 6. pp. 1435-1446.
@article{b465e2ddff6948a583bef78d95ef4f24,
title = "Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system",
abstract = "Nippostrongylus brasiliensis infection and ovalbumin-induced allergic lung pathology are highly interleukin (IL)-4/IL-13 dependent, but the contributions of IL-4/IL-13 from adaptive (T helper [Th]2 cells) and innate (eosinophil, basophils, and mast cells) immune cells remain unknown. Although required for immunoglobulin (Ig)E induction, IL-4/IL-13 from Th2 cells was not required for worm expulsion, tissue inflammation, or airway hyperreactivity. In contrast, innate hematopoietic cell-derived IL-4/IL-13 was dispensable for Th2 cell differentiation in lymph nodes but required for effector cell recruitment and tissue responses. Eosinophils were not required for primary immune responses. Thus, components of type 2 immunity mediated by IL-4/IL-13 are partitioned between T cell-dependent IgE and an innate non-eosinophil tissue component, suggesting new strategies for interventions in allergic immunity. JEM",
author = "David Voehringer and Reese, {Tiffany A.} and Xiaozhu Huang and Kanade Shinkai and Locksley, {Richard M.}",
year = "2006",
month = "6",
day = "12",
doi = "10.1084/jem.20052448",
language = "English (US)",
volume = "203",
pages = "1435--1446",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "6",

}

TY - JOUR

T1 - Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system

AU - Voehringer, David

AU - Reese, Tiffany A.

AU - Huang, Xiaozhu

AU - Shinkai, Kanade

AU - Locksley, Richard M.

PY - 2006/6/12

Y1 - 2006/6/12

N2 - Nippostrongylus brasiliensis infection and ovalbumin-induced allergic lung pathology are highly interleukin (IL)-4/IL-13 dependent, but the contributions of IL-4/IL-13 from adaptive (T helper [Th]2 cells) and innate (eosinophil, basophils, and mast cells) immune cells remain unknown. Although required for immunoglobulin (Ig)E induction, IL-4/IL-13 from Th2 cells was not required for worm expulsion, tissue inflammation, or airway hyperreactivity. In contrast, innate hematopoietic cell-derived IL-4/IL-13 was dispensable for Th2 cell differentiation in lymph nodes but required for effector cell recruitment and tissue responses. Eosinophils were not required for primary immune responses. Thus, components of type 2 immunity mediated by IL-4/IL-13 are partitioned between T cell-dependent IgE and an innate non-eosinophil tissue component, suggesting new strategies for interventions in allergic immunity. JEM

AB - Nippostrongylus brasiliensis infection and ovalbumin-induced allergic lung pathology are highly interleukin (IL)-4/IL-13 dependent, but the contributions of IL-4/IL-13 from adaptive (T helper [Th]2 cells) and innate (eosinophil, basophils, and mast cells) immune cells remain unknown. Although required for immunoglobulin (Ig)E induction, IL-4/IL-13 from Th2 cells was not required for worm expulsion, tissue inflammation, or airway hyperreactivity. In contrast, innate hematopoietic cell-derived IL-4/IL-13 was dispensable for Th2 cell differentiation in lymph nodes but required for effector cell recruitment and tissue responses. Eosinophils were not required for primary immune responses. Thus, components of type 2 immunity mediated by IL-4/IL-13 are partitioned between T cell-dependent IgE and an innate non-eosinophil tissue component, suggesting new strategies for interventions in allergic immunity. JEM

UR - http://www.scopus.com/inward/record.url?scp=33745036694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745036694&partnerID=8YFLogxK

U2 - 10.1084/jem.20052448

DO - 10.1084/jem.20052448

M3 - Article

C2 - 16702603

AN - SCOPUS:33745036694

VL - 203

SP - 1435

EP - 1446

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 6

ER -